Skip to main content
OpenTrials
Completed

NCT Number: NCT07507630

Ayres Sensory Integration in Preschool Children With Autism Spectrum Disorder

This study evaluates the effectiveness of occupational therapy using Ayres Sensory Integration® (ASI) in preschool children with autism spectrum disorder (ASD). The aim is to determine whether ASI, when added to usual individualized education program (IEP)-based education, improves adaptive functioning, goal attainment, and sensory processing.

Children aged 48 to 59 months with a diagnosis of ASD were recruited from a pediatric rehabilitation center in Istanbul, Türkiye. Participants were randomly assigned to either an intervention group receiving ASI in addition to usual care or a control group receiving usual care only.

The intervention lasted 12 weeks. Outcomes were assessed before and after the intervention using standardized measures including the Vineland Adaptive Behavior Scales-Second Edition (VABS-II), Goal Attainment Scaling (GAS), and the Sensory Profile.

The study is designed as a single-blind randomized controlled trial, with outcome assessments conducted by individuals who were not involved in the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

48 month–59 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rehabilitation Center

Istanbul, Uskudar, Turkey (Türkiye)

About this study

This single-blind randomized controlled trial was conducted to examine the effectiveness of occupational therapy using Ayres Sensory Integration® (ASI) in children with autism spectrum disorder (ASD). The study was carried out in a pediatric rehabilitation center in Istanbul, Türkiye between June 2021 and January 2023.

Participants were children aged 48 to 59 months who were diagnosed with ASD according to DSM-5-TR criteria and confirmed by a licensed child psychiatrist. Additional inclusion criteria included the presence of sensory processing difficulties identified through standardized assessments. Children with prior ASI intervention, significant neurological conditions, or additional developmental diagnoses were excluded.

After baseline assessment, participants were randomly assigned using a computer-based randomization system with concealed allocation. The intervention group received ASI delivered by a trained occupational therapist in addition to usual individualized education program (IEP)-based education. The ASI intervention consisted of approximately 36 hours over 12 weeks, typically delivered as three sessions per week, each lasting about 60 minutes. The control group continued to receive usual IEP-based educational services.

Outcome measures included adaptive functioning assessed by the Vineland Adaptive Behavior Scales-Second Edition (VABS-II), individualized goal performance measured by Goal Attainment Scaling (GAS), and sensory processing evaluated using the Sensory Profile. All outcomes were assessed at baseline and after the 12-week intervention period by evaluators who were blinded to group allocation.

The primary objective of the study was to determine whether ASI provides additional benefit beyond usual care in improving functional outcomes in children with ASD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 48 and 59 months
  • Diagnosis of autism spectrum disorder (ASD) according to DSM-5-TR, confirmed by a licensed child psychiatrist
  • Classification of ASD based on the Turkish Version of the Gilliam Autism Rating Scale-2 (TV-GARS-2)
  • Ongoing participation in an individualized education or therapy program during the study period
  • Presence of sensory processing difficulties identified through standardized assessments (e.g., Sensory Profile or Sensory Integration and Praxis Test)

Exclusion criteria

  • Previous or ongoing occupational therapy based on Ayres Sensory Integration®
  • Receiving educational or therapeutic services exceeding the individualized program
  • Presence of additional neurological or developmental conditions (e.g., cerebral palsy, Down syndrome)
  • Known seizure disorders or other significant neurological conditions

Treatment and study plan

Ayres Sensory Integration

Behavioral

Occupational therapy using Ayres Sensory Integration® delivered by a trained occupational therapist. The intervention was provided for approximately 12 weeks, typically three sessions per week, each lasting about 60 minutes.

Usual Care

Other

Individualized education program (IEP)-based educational services provided at the rehabilitation center, including interventions targeting language, cognitive, motor, social-emotional, and adaptive skills.

Primary outcomes

  1. Change in Goal Attainment Scaling (GAS) score

    Time frame: Baseline to 12 weeks

    Goal Attainment Scaling (GAS) was used to evaluate individualized functional goal achievement. Scores were assessed at baseline and after the 12-week intervention period.

Secondary outcomes

  1. Change in Vineland Adaptive Behavior Scales-Second Edition (VABS-II) scores

    Time frame: Baseline to 12 weeks

    Vineland Adaptive Behavior Scales-Second Edition (VABS-II) was used to assess adaptive functioning. Scores were assessed at baseline and after the 12-week intervention period.

  2. Change in Sensory Profile (SP) scores

    Time frame: Baseline to 12 weeks

    Sensory Profile (SP) was used to assess sensory processing patterns. Scores were assessed at baseline and after the 12-week intervention period.

Sponsors and collaborators

Lead sponsor

Medipol University

Other

Registry information

Official study title

Effectiveness of Ayres Sensory Integration® in Autism Spectrum Disorder: Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Apr 2, 2026
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.